cfDNA Methylation Assay for Clinical Evaluation of Patients With Stage IA Lung Cancer After Ablation Operation

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
The objective is to screen and monitor the efficacy of cfDNA methylation in patients with stage I lung cancer after ablation, to compare the similarities and differences of cfDNA methylation between surgical treatment and ablation in patients with stage I lung cancer, and to look for new indicators to assess the efficacy of ablation therapy and to monitor lung cancer recurrence.
Epistemonikos ID: ab9be4fd7701ee7a8f8f63aae0ecbb6da16d8c37
First added on: May 07, 2024